Fact CheckerSign in

NCT06642246Recruiting

Sleep Promotion and Pediatric Hypertension

Sleep Promotion Among Children Newly Diagnosed With Essential Hypertension

Source: ClinicalTrials.gov · Last updated 28 Aug 2026

Brief summary (registry, in English)

Determine the effectiveness and feasibility of a mobile health sleep extension approach in the pediatric nephrology setting, to increase sleep duration and reduce systolic and diastolic blood pressure.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
10 (estimated)
First submitted
4 Oct 2024
Start date
16 Feb 2026
Primary completion date
Nov 2026
Lead sponsor
Children's Hospital of Philadelphia
NCT number
NCT06642246

What you commit to

  • Study type: Interventional
  • Planned participants: 10
  • From 16 Feb 2026 to the primary completion date, Nov 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Any clinically diagnosed sleep disorder (e.g. sleep apnea) in the electronic health record and or regular use of prescribed sleep aide.
  • Underlying chronic medical conditions, defined as a medical condition with a duration or expected duration longer than 3 months that involved taking regular medication, taking medications that could affect blood pressure (e.g., anti-hypertensive medications, glucocorticoids, or stimulants), and patients with underlying diagnoses known to be associated with elevated blood pressure (e.g., cardiac disease, kidney disease or diabetes).

Other

  • \- Limited English proficiency

Who the study is looking for

  • Speak, read and write in English.
  • Parental/guardian permission (informed consent) and child assent.
  • Have a computer or a tablet computer with access to the Internet or own a smartphone with a data and text plan.
  • Parent reported sleep duration on school nights less than or equal to 7.5 hours.
  • Recently diagnosed with essential hypertension by Ambulatory Blood Pressure Monitoring (ABPM).
  • If taking over the counter sleep aides, willing to stop them over the course of the study.
  • Be the parent/guardian of an eligible child enrolled in the main study.
  • Speak, read, and write in English.

Age in the registry: 13 years to 18 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Children's Hospital of Philadelphia
Coordinator of this site? Confirm its status
PhiladelphiaUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.